217 related articles for article (PubMed ID: 37364331)
1. The interplay between microbial metabolites and macrophages in cardiovascular diseases: A comprehensive review.
Yang Y; Karampoor S; Mirzaei R; Borozdkin L; Zhu P
Int Immunopharmacol; 2023 Aug; 121():110546. PubMed ID: 37364331
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease.
Xue H; Chen X; Yu C; Deng Y; Zhang Y; Chen S; Chen X; Chen K; Yang Y; Ling W
Circ Res; 2022 Aug; 131(5):404-420. PubMed ID: 35893593
[TBL] [Abstract][Full Text] [Related]
3. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
Zhen J; Zhou Z; He M; Han HX; Lv EH; Wen PB; Liu X; Wang YT; Cai XC; Tian JQ; Zhang MY; Xiao L; Kang XX
Front Endocrinol (Lausanne); 2023; 14():1085041. PubMed ID: 36824355
[TBL] [Abstract][Full Text] [Related]
4. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
[TBL] [Abstract][Full Text] [Related]
5. Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.
Duttaroy AK
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33401598
[TBL] [Abstract][Full Text] [Related]
6. Trimethylamine
Canyelles M; Tondo M; Cedó L; Farràs M; Escolà-Gil JC; Blanco-Vaca F
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347638
[TBL] [Abstract][Full Text] [Related]
7. The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis.
Vourakis M; Mayer G; Rousseau G
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360839
[TBL] [Abstract][Full Text] [Related]
8. A Multi-omic Association Study of Trimethylamine N-Oxide.
Manor O; Zubair N; Conomos MP; Xu X; Rohwer JE; Krafft CE; Lovejoy JC; Magis AT
Cell Rep; 2018 Jul; 24(4):935-946. PubMed ID: 30044989
[TBL] [Abstract][Full Text] [Related]
9. Trimethylamine N-Oxide Generated by the Gut Microbiota: Potential Atherosclerosis Treatment Strategies.
Zhu B; Ren H; Xie F; An Y; Wang Y; Tan Y
Curr Pharm Des; 2022; 28(35):2914-2919. PubMed ID: 36121073
[TBL] [Abstract][Full Text] [Related]
10. Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice.
Liu C; Li Z; Song Z; Fan X; Shao H; Schönke M; Boon MR; Rensen PCN; Wang Y
Atherosclerosis; 2022 Dec; 362():47-55. PubMed ID: 36347649
[TBL] [Abstract][Full Text] [Related]
11. Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD).
Hemmati M; Kashanipoor S; Mazaheri P; Alibabaei F; Babaeizad A; Asli S; Mohammadi S; Gorgin AH; Ghods K; Yousefi B; Eslami M
Life Sci; 2023 Sep; 329():121947. PubMed ID: 37463653
[TBL] [Abstract][Full Text] [Related]
12. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Wang Z; Klipfell E; Bennett BJ; Koeth R; Levison BS; Dugar B; Feldstein AE; Britt EB; Fu X; Chung YM; Wu Y; Schauer P; Smith JD; Allayee H; Tang WH; DiDonato JA; Lusis AJ; Hazen SL
Nature; 2011 Apr; 472(7341):57-63. PubMed ID: 21475195
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
Cao H; Zhu Y; Hu G; Zhang Q; Zheng L
Pharmacol Res; 2023 Jan; 187():106586. PubMed ID: 36460280
[TBL] [Abstract][Full Text] [Related]
14. Trimethylamine
Naghipour S; Cox AJ; Peart JN; Du Toit EF; Headrick JP
Nutr Res Rev; 2021 Jun; 34(1):125-146. PubMed ID: 32718365
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of trimethylamine-N-oxide in the pathogenesis of atherosclerosis].
He H; Lian X; Tang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 42(8):986-990. PubMed ID: 28872093
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota-Derived Metabolites and Cardiovascular Disease Risk: A Systematic Review of Prospective Cohort Studies.
Sanchez-Gimenez R; Ahmed-Khodja W; Molina Y; Peiró OM; Bonet G; Carrasquer A; Fragkiadakis GA; Bulló M; Bardaji A; Papandreou C
Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807835
[TBL] [Abstract][Full Text] [Related]
17. Microbiota-Mediated Immune Regulation in Atherosclerosis.
Eshghjoo S; Jayaraman A; Sun Y; Alaniz RC
Molecules; 2021 Jan; 26(1):. PubMed ID: 33401401
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of proline/serine-rich coiled-coil protein 1 (PSRC1) accelerates trimethylamine N-oxide-induced atherosclerosis in ApoE
Luo T; Liu D; Guo Z; Chen P; Guo Z; Ou C; Chen M
J Mol Cell Cardiol; 2022 Sep; 170():60-74. PubMed ID: 35690006
[TBL] [Abstract][Full Text] [Related]
19. Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism.
Anto L; Blesso CN
J Nutr Biochem; 2022 Jul; 105():108991. PubMed ID: 35331903
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
